SCHEMBL735172

SCHEMBL735172

CC(Sc1ncnc2[nH]cnc12)c1nc2ccc(Br)cc2c(=O)n1-c1ccccc1Cl

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PIK3CG P48736 7/20 0.42
POLB P06746 1/20 0.42
RECQL P46063 1/20 0.42
PIK3CD O00329 4/20 0.37
PIK3C3 Q8NEB9 1/20 0.37
PIK3R1 P27986 3/20 0.36
PIK3CA P42336 2/20 0.36
PIK3CB P42338 2/20 0.36
PAK1 Q13153 1/20 0.35
PTGS2 P35354 1/20 0.35
HPD P32754 2/20 0.35
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
HPGD P15428 1/20 0.34
CYP2C19 P33261 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL734271 0.82 PIK3CG (0.38) PIK3CGPOLBRECQLPIK3CDPIK3C3
SCHEMBL734272 0.82 PIK3CG (0.61) PIK3CGPOLBRECQLPIK3CDPIK3CB
SCHEMBL735173 0.80 PIK3CG (0.51) PIK3CGPOLBRECQLPIK3CDPIK3CB
SCHEMBL1460987 0.77 PIK3CG (0.54) PIK3CGPOLBRECQLPIK3CDPIK3CB
SCHEMBL16677424 0.74 PIK3CD (0.62) PIK3CGPIK3CDPIK3C3PIK3R1PIK3CA
SCHEMBL16677626 0.74 PIK3CD (0.62) PIK3CGPIK3CDPIK3C3PIK3R1PIK3CA
SCHEMBL16677702 0.74 PIK3CD (0.62) PIK3CGPIK3CDPIK3C3PIK3R1PIK3CA
SCHEMBL734505 0.74 PIK3CG (0.39) PIK3CGPOLBRECQLPIK3CDPIK3C3
SCHEMBL734506 0.73 PIK3CG (0.63) PIK3CGPOLBRECQLPIK3CDPIK3CB
SCHEMBL734435 0.73 PIK3CG (0.39) PIK3CGPOLBRECQLPIK3CDPIK3C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138195-B2 Inhibitors of human phosphatidylinositol 3-kinase delta ICOS CORPORATION (US) 2012-03-20 US disclosed
US-20050261317-A1 Inhibitors of human phosphatidylinositol 3-kinase delta ICOS CORPORATION (US) 2005-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050261317-A1 Inhibitors of human phosphatidylinositol 3-kinase delta PIK3CD, PIK3R5, PIK3CA PIK3CG 4/4885POLB 933/4885RECQL 3005/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.